Quarterly report pursuant to Section 13 or 15(d)
Cover
Cover
Financial Statements
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
Condensed Consolidated Statements of Stockholders Equity (Unaudited)
Condensed Consolidated Statements of Cash Flows (Unaudited)
Notes to Financial Statements
Nature of Business and Liquidity
Significant Accounting Policies
Investments
Capital Stock
Stock Incentive Plan
Related Party Transactions
Commitments and Contingencies
Accounting Policies
Significant Accounting Policies (Policies)
Notes Tables
Significant Accounting Policies (Tables)
Investments (Tables)
Stock Incentive Plan (Tables)
Notes Details
Nature of Business and Liquidity (Details Narrative)
Significant Accounting Policies (Details)
Significant Accounting Policies (Details Narrative)
Investments (Details)
Investments (Details Narrative)
Capital Stock (Details Narrative)
Stock Incentive Plan (Details)
Stock Incentive Plan (Details 1)
Stock Incentive Plan (Details 2)
Stock Incentive Plan (Details 3)
Stock Incentive Plan (Details Narrative)
Related Party Transactions (Details Narrative)
Commitments and Contingencies (Details)
Related Party Transactions (Details Narrative)
v3.23.1
Related Party Transactions (Details Narrative)
3 Months Ended
Mar. 31, 2023
Tactic Pharma LLC
Beneficial ownership
32.40%
X
- References
No definition available.
+ Details
Name:
mnpr_BeneficialOwnershipPercentage
Namespace Prefix:
mnpr_
Data Type:
num:percentItemType
Balance Type:
na
Period Type:
duration
X
- Details
Name:
us-gaap_RelatedPartyTransactionAxis=mnpr_TacticPharmaLlcMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type: